1352 related articles for article (PubMed ID: 24953245)
21. [Regulation of all-trans retinoic acid and arsenic trioxide on CD44v6 expression in NB4 cells].
Huang HF; Chen P; Lu R; Lin ZX; Wu Y; Chen YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):33-7. PubMed ID: 22391160
[TBL] [Abstract][Full Text] [Related]
22. Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.
Atashrazm F; Lowenthal RM; Dickinson JL; Holloway AF; Woods GM
Oncotarget; 2016 Jul; 7(29):46028-46041. PubMed ID: 27329592
[TBL] [Abstract][Full Text] [Related]
23. Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome.
Luesink M; Pennings JL; Wissink WM; Linssen PC; Muus P; Pfundt R; de Witte TJ; van der Reijden BA; Jansen JH
Blood; 2009 Dec; 114(27):5512-21. PubMed ID: 19828696
[TBL] [Abstract][Full Text] [Related]
24. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].
Xu SN; Chen JP; Liu JP; Xia Y
Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733
[TBL] [Abstract][Full Text] [Related]
25. Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide.
Borges GSM; Sicard P; de Mello Gomides Loures C; Evangelista FGC; Sales CC; de Paula Sabino A; Fernandes C; Ferreira LAM; Richard S
AAPS PharmSciTech; 2023 Mar; 24(3):79. PubMed ID: 36918482
[TBL] [Abstract][Full Text] [Related]
26. What is the role of arsenic in newly diagnosed APL?
Tallman MS
Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells.
Huynh TT; Sultan M; Vidovic D; Dean CA; Cruickshank BM; Lee K; Loung CY; Holloway RW; Hoskin DW; Waisman DM; Weaver ICG; Marcato P
Sci Rep; 2019 Jul; 9(1):9414. PubMed ID: 31263158
[TBL] [Abstract][Full Text] [Related]
28. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
Grimwade D; Mistry AR; Solomon E; Guidez F
Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254
[TBL] [Abstract][Full Text] [Related]
29. An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid.
Wang G; Li W; Cui J; Gao S; Yao C; Jiang Z; Song Y; Yuan CJ; Yang Y; Liu Z; Cai L
Hematol Oncol; 2004 Jun; 22(2):63-71. PubMed ID: 15468344
[TBL] [Abstract][Full Text] [Related]
30. Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL.
Humbert M; Federzoni EA; Tschan MP
J Leukoc Biol; 2017 Dec; 102(6):1357-1370. PubMed ID: 28978663
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of all-trans retinoic acid-linked arsenic trioxide treatment for acute promyelocytic leukemia.
Chen L; Wang J; Hu X; Xu X
Hematology; 2014 Jun; 19(4):202-7. PubMed ID: 24074286
[TBL] [Abstract][Full Text] [Related]
32. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
[TBL] [Abstract][Full Text] [Related]
33. Glycolytic metabolism confers resistance to combined all-trans retinoic acid and arsenic trioxide-induced apoptosis in HL60rho0 cells.
Herst PM; Hesketh EL; Ritchie DS; Berridge MV
Leuk Res; 2008 Feb; 32(2):327-33. PubMed ID: 17580091
[TBL] [Abstract][Full Text] [Related]
34. [Effects of cucurmosin combined with common chemotherapeutics on proliferation and apoptosis of NB4 cells].
Xle JM; Liu M; Liu TB; Chen MH; Yang AQ; Yang P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1327-31. PubMed ID: 23257426
[TBL] [Abstract][Full Text] [Related]
35. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
36. cAMP protects acute promyelocytic leukemia cells from arsenic trioxide-induced caspase-3 activation and apoptosis.
Safa M; Mousavizadeh K; Noori S; Pourfathollah A; Zand H
Eur J Pharmacol; 2014 Aug; 736():115-23. PubMed ID: 24815320
[TBL] [Abstract][Full Text] [Related]
37. Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide.
Sun Y; Kim SH; Zhou DC; Ding W; Paietta E; Guidez F; Zelent A; Ramesh KH; Cannizzaro L; Warrell RP; Gallagher RE
Leukemia; 2004 Jul; 18(7):1258-69. PubMed ID: 15116119
[TBL] [Abstract][Full Text] [Related]
38. [Enhancement of all-trans retinoic acid-induced differentiation by bufalin in primary culture of acute promyelocytic leukemia cells].
Zhu ZT; Jin B; Liu YP; Li YC; Lu XL; Tian X; Hou KZ
Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):314-7. PubMed ID: 16780682
[TBL] [Abstract][Full Text] [Related]
39. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM
Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984
[TBL] [Abstract][Full Text] [Related]
40. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
Zuo L; Li J; Yang Y; Wang X; Shen T; Xu CM; Zhang ZN
Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
